Abstract
P105 - Is achieving undetectable PSA (uPSA) a prognostic factor for improved overall survival (OS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving intensified treatments?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have